BAC Medical Nordic ApS: Financial statements 2023
CVR: 36928638
Source: annual report 2023, Danish Business Authority
01/07/2022 – 30/06/2023
BAC Medical Nordic ApS (CVR 36928638) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -187,967 and a net result of DKK -354,292 compared with DKK 193,120 the year before. Equity in the 2023 report amounted to DKK 648,108. The solvency ratio was 50.5%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -187,967
- Profit/Loss
- DKK -354,292
- Equity
- DKK 648,108
- Total Assets
- DKK 1,282,160
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -188K | -354K | 648K | 1 |
| 2022 | - | 485K | 193K | 1M | 1 |
| 2021 | - | 187K | 13K | 809K | 1 |
| 2020 | - | 784K | 516K | 796K | 1 |
| 2019 | - | 185K | 109K | 388K | 0 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
BAC Medical Nordic ApS has published its annual report for 2022. Gross profit came to DKK 485,374, and the net result was DKK 193,120.
About BAC Medical Nordic ApS
BAC Medical Nordic ApS is a Danish company of the type Anpartsselskab based in Charlottenlund, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Qu Wang. The company is owned by BAC Nordic Holding ApS. The company has 0 employees (2017). In 2025, the company reported revenue of DKK 3,774,580 and a net result of DKK 561,343 compared with DKK 88,434 the year before. Equity in the 2025 report amounted to DKK 1,076,699.
